This page contains links to Measles & Rubella Partnership advocacy materials, the latest data and technical guidance that is useful for people interested in, or working in immunization
2024 Annual Report
The global fight against measles and rubella is marked by both progress and deep inequities. While more countries have reached elimination milestones, global vaccination rates remain stagnant. The latest coverage data from 2023* showed that first dose of measles vaccination coverage remained at 83%, the same as in 2022. As a result, over 22 million children missed a vital first dose of the measles vaccine.
Prelude Version 2.3.2